Sarepta Therapeutics (SRPT) Operating Income (2010 - 2026)
Sarepta Therapeutics' quarterly Operating Income came in at $358.4 million in Q1 2026, up 219.32% year-on-year from $112.2 million in Q1 2025, and up 187.09% quarter-over-quarter from -$411.6 million in Q4 2025.
Sarepta Therapeutics has reported Operating Income for 17 years, with the latest figure at $358.4 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 219.32% year-over-year to $358.4 million; the trailing twelve-month figure through Mar 2026 stood at -$41.0 million (up 65.05% YoY), and the FY2025 full-year result was -$699.8 million, down 420.88% from the prior year.
- Operating Income for Q1 2026 stood at $358.4 million, up from -$411.6 million in the prior quarter.
- The five-year high for Operating Income was $358.4 million in Q1 2026, with the low at -$411.6 million in Q4 2025.
- Average Operating Income over 5 years is -$54.5 million, with a median of -$86.9 million recorded in 2022.
- Peak annual rise in Operating Income reached 16587.45% in 2025, while the deepest fall reached 960.58% in 2025.
- Tracing SRPT's Operating Income over 5 years: stood at -$106.8 million in 2022, then jumped by 123.05% to $24.6 million in 2023, then surged by 556.57% to $161.7 million in 2024, then sank by 354.56% to -$411.6 million in 2025, then jumped by 187.09% to $358.4 million in 2026.
- The last three Operating Income figures came in at $358.4 million (Q1 2026), -$411.6 million (Q4 2025), and -$103.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 358.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 358.43 Mn |
| Dec 31, 2025 | -411.58 Mn |
| Sep 30, 2025 | -103.39 Mn |
| Jun 30, 2025 | 115.58 Mn |
| Mar 31, 2025 | -300.39 Mn |
| Dec 31, 2024 | 161.68 Mn |
| Sep 30, 2024 | 22.20 Mn |
| Jun 30, 2024 | -701,000.00 |
| Mar 31, 2024 | 34.91 Mn |
| Dec 31, 2023 | 24.63 Mn |
| Sep 30, 2023 | -20.84 Mn |
| Jun 30, 2023 | -133.52 Mn |
| Mar 31, 2023 | -138.09 Mn |
| Dec 31, 2022 | -106.83 Mn |
| Sep 30, 2022 | -131.36 Mn |
| Jun 30, 2022 | -211.13 Mn |
| Mar 31, 2022 | -86.88 Mn |
| Dec 31, 2021 | -105.81 Mn |
| Sep 30, 2021 | -34.46 Mn |
| Jun 30, 2021 | -167.57 Mn |
| Mar 31, 2021 | -151.87 Mn |
| Dec 31, 2020 | -170.72 Mn |
| Sep 30, 2020 | -137.07 Mn |
| Jun 30, 2020 | -138.35 Mn |
| Mar 31, 2020 | -118.03 Mn |
| Dec 31, 2019 | -230.22 Mn |
| Sep 30, 2019 | -123.59 Mn |
| Jun 30, 2019 | -275.37 Mn |
| Mar 31, 2019 | -76.39 Mn |
| Dec 31, 2018 | -139.36 Mn |
| Sep 30, 2018 | -70.10 Mn |
| Jun 30, 2018 | -103.43 Mn |
| Mar 31, 2018 | -30.74 Mn |
| Dec 31, 2017 | -23.15 Mn |
| Sep 30, 2017 | -45.91 Mn |
| Jun 30, 2017 | -63.34 Mn |
| Mar 31, 2017 | -39.25 Mn |
| Dec 31, 2016 | -88.40 Mn |
| Sep 30, 2016 | -56.53 Mn |
| Jun 30, 2016 | -62.10 Mn |
| Mar 31, 2016 | -59.70 Mn |
| Dec 31, 2015 | -64.45 Mn |
| Sep 30, 2015 | -51.76 Mn |
| Jun 30, 2015 | -42.11 Mn |
| Mar 31, 2015 | -61.86 Mn |
| Dec 31, 2014 | -44.72 Mn |
| Sep 30, 2014 | -33.68 Mn |
| Jun 30, 2014 | -30.27 Mn |
| Mar 31, 2014 | -25.12 Mn |
| Dec 31, 2013 | -32.85 Mn |
| Sep 30, 2013 | -24.93 Mn |
| Jun 30, 2013 | -17.09 Mn |
| Mar 31, 2013 | -15.42 Mn |
| Dec 31, 2012 | -10.37 Mn |
| Sep 30, 2012 | -6.91 Mn |
| Jun 30, 2012 | -5.56 Mn |
| Mar 31, 2012 | -6.87 Mn |
| Dec 31, 2011 | -9.00 Mn |
| Sep 30, 2011 | -11.27 Mn |
| Jun 30, 2011 | -10.13 Mn |
| Mar 31, 2011 | -5.53 Mn |
| Dec 31, 2010 | -1.74 Mn |
| Sep 30, 2010 | -3.80 Mn |
| Jun 30, 2010 | -7.67 Mn |